의료 권고사항

Summary of NACI statement of May 24, 2024: Interim guidance on the use of Imvamune® in the context of a routine immunization program

National Advisory Committee on Immunization예방접종2024공식 발행

ASEM 문헌 요약

Official National Advisory Committee on Immunization document (2024) on “Summary of NACI statement of May 24, 2024: Interim guidance on the use of Imvamune® in the context of a routine immunization program”. Valid as of May 24, 2024: Summary of the National Advisory Committee on Immunization's interim guidance on the use of Imvamune in the context of a routine immunization program.

이 요약은 문서를 식별하는 데 도움이 됩니다. 임상 권고사항은 항상 공식 버전과 업데이트 날짜를 확인하십시오.

공식 문서

관련 진료지침

Summary of NACI statement of May 2026: Statement on seasonal influenza vaccines for 2026-2027 Summary of NACI statement of June 2026: Guidance on the use of COVID-19 vaccines starting fall 2026 Summary of updates in the Canadian Immunization Guide as of March 31, 2025: Updated guidance on quadrivalent conjugate meningococcal vaccines available in Canada